Keyphrases
Cancer Patients
70%
Depressive Symptoms
63%
Sexual Behavior
55%
Psychological Intervention
40%
Gynecological Cancer
39%
Quality of Life
38%
Breast Cancer
36%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
34%
Cancer Survivors
30%
Cancer Treatment
30%
Biobehavioral
29%
In Cancer
28%
Biobehavioral Intervention
27%
Breast Cancer Patients
26%
Sexuality
26%
Cancer Diagnosis
25%
Chronic Lymphocytic Leukemia
25%
Oncology
25%
Sexual Self-schema
24%
Breast Cancer Survivors
24%
Anxiety Symptoms
22%
Sexual Dysfunction
22%
Gynecologic Cancer Survivors
21%
Psychologic
19%
Distress Management
18%
Psychological Reactance
17%
Breast Cancer Recurrence
17%
Survivors
17%
Patients with Breast Cancer
16%
Illness Perceptions
16%
Psychosocial Outcomes
16%
Female Cancer
15%
Gynecologic Oncology
15%
Allostatic Load
15%
Sexual Morbidity
14%
Breast
13%
Sexual Outcomes
13%
Clinical Practice Guidelines
12%
Physical Functioning
12%
Emotional Distress
12%
Empirical Therapy
12%
Meaning in Life
12%
Psychological Adjustment
12%
Patients with Cancer
11%
Self-view
11%
Sexual Difficulties
11%
Sexual Self-concept
11%
Older Adults
11%
Relapsed or Refractory
11%
Sexual Problems
11%
Medicine and Dentistry
Malignant Neoplasm
100%
Breast Cancer
63%
Female Genital Tract Cancer
30%
Quality of Life
20%
Depression
20%
Oncology
20%
Cancer Therapy
15%
Disease
15%
Gynecological Oncology
15%
Mental Health
12%
B-Cell Chronic Lymphocytic Leukemia
12%
Lung Cancer
11%
Non Small Cell Lung Cancer
10%
Survivorship in Cancer Care
10%
Clinical Oncology
10%
Supportive Care
9%
Psychosocial Oncology
9%
Overall Survival
8%
Immunotherapy
8%
Natural Killer Cell
8%
Sequela
8%
Cancer
7%
Self Concept
7%
Cervical Cancer
6%
Cancer Diagnosis
6%
Chemotherapy
6%
Comorbidity
6%
Attitude
6%
Immunity
6%
Obinutuzumab
6%
Low and Middle Income Countries
6%
Immune-Related Adverse Events
6%
Recurrent Disease
5%
Clinician
5%
Health Care
5%
Immune Response
5%
Posttraumatic Stress Disorder
5%
Hazard Ratio
5%
Drug Therapy
5%
Chemoprophylaxis
5%
Cellular Immunity
5%
Functional Status
5%
Lymphocyte
5%
Cytotoxicity
5%